U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647848) titled 'Therapy Adjustment and IndividuaLized Response With Biomarker Observation in ReaL-world Heart Failure' on June 03.
Brief Summary: The goal of TAILOR-HF is to integrate clinical data, laboratory parameters, treatment patterns, and circulating biomarkers to identify factors that predict individual response to pharmacological treatment in patients with heart failure.
TAILOR-HF is an observational study with protocol-mandated assessments scheduled at baseline and at 1, 3, and 6 months after enrolment. Additional follow-up data will be collected through telephone visits every 6 months until the last participant has completed the protoco...